Talking to ET Now, R Sreesankar , Head-Institutional Equities, Prabhudas Lilladher , says if the currency depreciates, that will be a tailwind for even IT and probably pharma. Edited excerpts: Analysing the outperformance in IT, we see a large part of the gains have already been made.
For More Details Visit-
via IT mid-caps to continue to outperform: R Sreesankar, Prabhudas Lilladher
No comments:
Post a Comment